RYAN vs SRPT · P/E 43, rev $2.46B vs rev $1.90B
Ryan Specialty Group Holdings Inc (RYAN) versus Sarepta Therapeutics Inc (SRPT) — a side-by-side from cached financials, not a winner call.
Ryan Specialty Group Holdings Inc (RYAN) is a insurance - specialty company listed on NYSE.
Sarepta Therapeutics Inc (SRPT) is a biotechnology company listed on US.
Latest reported RYAN revenue for 2024-12-31 was $2.46B. Net income was $229.9M. Revenue was up 21.2% from 2023-12-31 to 2024-12-31. RYAN currently screens at market cap $9.33B and trailing P/E 43.1.
Latest reported SRPT revenue for 2024-12-31 was $1.90B. Net income was $235.2M. Revenue was up 53.0% from 2023-12-31 to 2024-12-31. SRPT currently screens at market cap $2.34B.
RYAN currently screens at market cap $9.33B and trailing P/E 43.1. SRPT currently screens at market cap $2.34B.
Not investment advice. Open the RYAN and SRPT stock pages for the full models.
Not investment advice.